Classic bladder exstrophy and adenocarcinoma of the bladder: Methylome analysis provide no evidence for underlying disease-mechanisms of this association.
Adenocarcinoma
/ genetics
Bladder Exstrophy
/ genetics
Cell Cycle Proteins
/ genetics
DNA Methylation
/ genetics
Humans
LIM-Homeodomain Proteins
/ genetics
Promoter Regions, Genetic
/ genetics
Transcription Factors
/ genetics
Tumor Suppressor Proteins
/ genetics
Urinary Bladder
/ pathology
Urinary Bladder Neoplasms
/ genetics
Adenocarcinoma of the urinary bladder
Classic bladder exstrophy
DNA methylation
Journal
Cancer genetics
ISSN: 2210-7762
Titre abrégé: Cancer Genet
Pays: United States
ID NLM: 101539150
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
22
05
2018
revised:
27
03
2019
accepted:
29
05
2019
entrez:
13
7
2019
pubmed:
13
7
2019
medline:
7
3
2020
Statut:
ppublish
Résumé
The bladder exstrophy-epispadias complex (BEEC) represents the severe end of uro-rectal malformation spectrum involving aberrant embryonic morphogenesis of the cloacal membrane and the urorectal septum. The most common form of BEEC is isolated classic bladder exstrophy (CBE). Long-term complications in CBE are malignancies of the bladder with 95% of them being adenocarcinomas. Since CBE and adenocarcinoma of the bladder are rare entities, their frequent co-occurrence suggests a common etiology. Recent studies suggest that promoter methylation of various genes play a crucial role during the phenotypical morphogenesis of adenocarcinomas of urinary bladder. To examine, whether epigenetic processes such as DNA methylation patterns are potentially associated with CBE, we performed Illumina 450 K methylation arrays in blood (n = 10) and tissue samples (n = 2) of CBE patients and healthy matched controls (n = 12). In our analysis, we found total lack of methylation in the blood and methylation differences were restricted to 10 CpG sites in the tissue samples. In comparison to other bladder anomalies, CBE tissue methylation profiles differ from those of adenocarcinoma, adenocarcinoma with CBE, urothelial carcinoma and urachal carcinoma. In this preliminary study, we did not provide any strong evidence of major DNA methylation alterations which would be suggestive for strong underlying epigenetic mechanism. However, larger studies are required to provide more robust statistical evidence to exclude smaller effects in the tissues.
Identifiants
pubmed: 31296310
pii: S2210-7762(18)30279-5
doi: 10.1016/j.cancergen.2019.05.004
pii:
doi:
Substances chimiques
Cell Cycle Proteins
0
LIM-Homeodomain Proteins
0
PLAGL1 protein, human
0
Transcription Factors
0
Tumor Suppressor Proteins
0
insulin gene enhancer binding protein Isl-1
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18-20Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.